ATP and acetylcholine, equal brethren

Neurochemistry International

Volumn 52, Issue 4-5, 2008, Pages 634-648

  Zimmermann, Herbert ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Acetylcholine; ATP; Ecto nucleotidase; Muscarinic acetylcholine receptor; Nicotinic acetylcholine receptor; P2 receptor

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; CHOLINE ACETYLTRANSFERASE; METABOTROPIC RECEPTOR; PURINERGIC P2X RECEPTOR; VESICULAR ACETYLCHOLINE TRANSPORTER;

ACETYLATION; ALZHEIMER DISEASE; ATTENTION DEFICIT DISORDER; BINDING AFFINITY; CALCIUM TRANSPORT; HUMAN; MEMBRANE VESICLE; MYASTHENIA LIKE SYNDROME; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION;

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ANIMALS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; HYDROLYSIS; RECEPTORS, CHOLINERGIC; TISSUE DISTRIBUTION; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 38349101862     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.09.004     Document Type: Review

References (232)

1. Abbracchio M.P., and Burnstock G. Purinergic signalling: Pathophysiological roles. Jpn. J. Pharmacol. 78 (1998) 113-145
2. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., Knight G.E., Fumagalli M., Gachet C., Jacobson K.A., and Weisman G.A. International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58 (2006) 281-341
3. Abood L.G., and Gerard R.W. Enzyme distribution in isolated particulates of rat peripheral nerve. J. Cell Physiol. 43 (1954) 379-392
4. Acs G., Ostrowski W., and Straub F.B. Adenylpyrophosphatase activity on the surface of ascites tumor cells. Acta Physiol. Hung. 6 (1954) 261-263
5. Alkondon M., Pereira E.F., Cortes W.S., Maelicke A., and Albuquerque E.X. Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur. J. Neurosci. 9 (1997) 2734-2742
6. Anderson C.M., and Parkinson F.E. Potential signalling roles for UTP and UDP: sources, regulation and release of uracil nucleotides. Trends. Pharmacol. Sci. 18 (1997) 387-392
7. Augustinsson K.B., and Nachmansohn D. Distinction between acetylcholinesterase and other choline ester-splitting enzymes. Science 110 (1949) 98-99
8. Baddiley J., Michelson A.M., and Todd A.R. Nucleotides. Part II. A synthesis of adenosine triphosphate. J. Chem. Soc. (1949) 582-586
9. Baeyer A. Notes from the organic laboratory of the Gewerbeacademie in Berlin I. On the neurin. Liebigs. Ann. 142 (1867) 322-326
10. Baldwin S.A., Beal P.R., Yao S.Y., King A.E., Cass C.E., and Young J.D. The equilibrative nucleoside transporter family SLC29. Pflügers Arch. 447 (2004) 735-743
11. Berrard S., Brice A., Lottspeich F., Braun A., Barde Y.A., and Mallet J. cDNA cloning and complete sequence of porcine choline acetyltransferase: in vitro translation of the corresponding RNA yields an active protein. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 9280-9284
12. Bianchi V., and Spychala J. Mammalian 5′nucleotidases. J. Biol. Chem. 278 (2003) 46195-46198
13. Bours M.J., Swennen E.L., Di V.F., Cronstein B.N., and Dagnelie P.C. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112 (2006) 358-404
14. Brake A.J., Wagenbach M.J., and Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371 (1994) 519-523
15. Braun M., Wendt A., Karanauskaite J., Galvanovskis J., Clark A., MacDonald P.E., and Rorsman P. Corelease and differential exit via the fusion pore of GABA, serotonin, and ATP from LDCV in rat pancreatic beta cells. J. Gen. Physiol. 129 (2007) 221-231
16. Burnstock G. Noradrenaline and ATP: Cotransmitters and neuromodulators. J. Physiol. Pharmacol. (1995) 365-384
17. Burnstock G. Purinergic nerves. Pharmacol. Rev. 24 (1972) 509-581
18. Burnstock G. Do some nerve cells release more than one transmitter?. Neurosience 1 (1976) 239-248
19. Burnstock G. A basis for distinguishing two types of purinergic receptor. In: Straub R.W., and Bolis L. (Eds). Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach (1978), Raven Press, New York 107-118
20. Burnstock G. Noradrenaline and ATP: cotransmitters and neuromodulators. J. Physiol. Pharmacol. (1995) 365-384
21. Burnstock G. Cotransmission. Curr. Opin. Pharmacol. 4 (2004) 47-52
22. Burnstock G. Purinergic P2 receptors as targets for novel analgesics. Pharmacol. Ther. 110 (2006) 433-454
23. Burnstock G. Purinergic signalling. Br. J. Pharmacol. 147 (2006) S172-S181
24. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci. 27 (2006) 166-176
25. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 58 (2006) 58-86
26. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87 (2007) 659-797
27. Burnstock G., Campbell G., Satchell D., and Smythe A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br. J. Pharmacol. 40 (1970) 668-688
28. Burnstock G., and Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor?. Gen. Pharmacol. 16 (1985) 433-440
29. Burnstock G., and Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240 (2004) 31-304
30. 1 ATPase: metabolic and immunological functions. Curr. Opin. Lipidol. 17 (2006) 279-284
31. Chizh B.A., and Illes P. P2X receptors and nociception. Pharmacol. Rev. 53 (2000) 553-568
32. Ciana P., Fumagalli M., Trincavelli M.L., Verderio C., Rosa P., Lecca D., Ferrario S., Parravicini C., Capra V., Gelosa P., Guerrini U., Belcredito S., Cimino M., Sironi L., Tremoli E., Rovati G.E., Martini C., and Abbracchio M.P. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J. 25 (2006) 4615-4627
33. Clarkson E.M., and Maizels M. Distribution of phosphatase in human erythrocytes. J. Physiol. Lond. 116 (1952) 112-128
34. Coco S., Calegari F., Pravettoni E., Pozzi D., Taverna E., Rosa P., Matteoli M., and Verderio C. Storage and release of ATP from astrocytes in culture. J. Biol. Chem. 278 (2003) 1354-1362
35. Comella C.L., and Pullman S.L. Botulinum toxins in neurological disease. Muscle Nerve 29 (2004) 628-644
36. Conti-Fine B.M., Milani M., and Kaminski H.J. Myasthenia gravis: past, present, and future. J. Clin. Invest. 116 (2006) 2843-2854
37. Corringer P.J., Le N.N., and Changeux J.P. Nicotinic receptors at the amino acid level. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 431-458
38. Couteaux R., and Nachmansohn D. Changes of cholinesterase at end-plates of voluntary muscles following section of sciatic nerve. Proc. Soc. Exp. Biol. (N.Y.) 43 (1940) 177-181
39. Dajas-Bailador F., and Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25 (2004) 317-324
40. Dale H.H. The action of certain esters and ethers of choline, and their relation to muscarine. J. Pharmacol. Exp. Ther. 6 (1914) 147-190
41. Dale H.H., and Dudley H.W. The presence of histamine and acetylcholine in the spleen of the ox and the horse. J. Physiol. 68 (1929) 97-123
42. Dale H.H., Feldberg W., and Vogt M. Release of acetylcholine at voluntary motor nerve endings. J. Physiol. 86 (1936) 353-380
43. Dasgupta P., and Chellappan S.P. Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 5 (2006) 2324-2328
44. Delicado E.G., Miras-Portugal M.T., Carrasquero L.M.G., León D., Pérez-Sen R., and Gualix J. Dinucleoside polyphosphates and their interaction with other nucleotide signaling pathways. Pflügers Arch. Eur. J. Physiol. 452 (2006) 563-572
45. Devillers-Thiéry A., Galzi J.L., Eisele J.L., Bertrand S., Bertrand D., and Changeux J.P. Functional architecture of the nicotinic acetylcholine receptor-A prototype of ligand-gated ion channels. J. Membr. Biol. 136 (1993) 97-112
46. Díaz-Hernández M., Pintor J., Castro E., and Miras-Portugal M.T. Co-localisation of functional nicotinic and ionotropic nucleotide receptors in isolated cholinergic synaptic terminals. Neuropharmacology 42 (2002) 20-33
47. Dowdall M.J., Boyne A.F., and Whittaker V.P. Adenosine triphosphate, a constituent of cholinergic synaptic vesicles. Biochem. J. 140 (1974) 1-12
48. Drury A.N., and Szent-Gyorgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J. Physiol. 68 (1929) 213-237
49. 7 receptors: properties and relevance to CNS function. Glia 54 (2006) 738-746
50. Dudley H.W. Observations on acetylcholine. Biochem. J. 23 (1929) 1064-1074
51. Edwards F.A., Gibb A.J., and Colquhoun D. ATP receptor-mediated synaptic currents in the central nervous system. Nature 359 (1992) 144-147
52. Eglen R.M. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Auton. Autacoid. Pharmacol. 26 (2006) 219-233
53. Eiden L.E. The cholinergic gene locus. J. Neurochem. 70 (1998) 2227-2240
54. Eiden L.E., Schafer M.K.H., Weihe E., and Schutz B. The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine. Pflügers Arch. Eur. J. Physiol. 447 (2004) 636-640
55. Engelhardt W.A. Enzymes as structural elements of physiological mechanism. Proc. Int. Symp. Enzyme Chem. 2 (1958) 163-166
56. Erb L., Liao Z., Seye C.I., and Weisman G.A. P2 receptors: intracellular signaling. Pfluger Arch. 452 (2006) 552-562
57. Erickson J.D., Varoqui H., Schäfer M.K.H., Modi W., Diebler M.F., Weihe E., Rand J., Eiden L.E., Bonner T.I., and Usdin T.B. Functional identification of a vesicular acetylcholine transp4orter and its expression from a "cholinergic" gene locus. J. Biol. Chem. 269 (1994) 21929-21932
58. Espallergues J., Solovieva O., Techer V., Bauer K., Alonso G., Vincent A., and Hussy N. Synergistic activation of astrocytes by ATP and norepinephrine in the rat supraoptic nucleus. Neuroscience (2007)
59. Essner E., Novikoff A.B., and Masek B. Adenosine triphosphatase and 5′-nucleotidase activities in the plasma membrane of liver cells as revealed by electron microscopy. J. Biophys. Biochem. Cytol. 4 (1958) 711-716
60. Evans R.J., Derkach V., and Surprenant A. ATP mediates fast synaptic transmission in mammalian neurons. Nature 357 (1992) 503-505
61. Ewins A.J. Some new physiologically active derivatives of choline. Biochem. J. 8 (1914) 366-373
62. Fabbro A., Skorinkin A., Grandolfo M., Nistri A., and Giniatullin R. Quantal release of ATP from clusters of PC12 cells. J. Physiol. Lond. 560 (2004) 505-517
63. Fatt P., and Katz B. Spontaneous subthreshold activity at motor nerve endings. J. Physiol. 117 (1952) 109-128
64. Fellin T., Sul J.Y., D'Ascenzo M., Takano H., Pascual O., and Haydon P.G. Bidirectional astrocyte-neuron communication: the many roles of glutamate and ATP. Novartis Found. Symp. 276 (2006) 208-217
65. 7 gene increases susceptibility to extrapulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 175 (2007) 360-366
66. Fields R.D., and Burnstock G. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 7 (2006) 423-436
67. Fiske C.H., and SubbaRow Y. Phosphorous compounds of muscle and live. Science 70 (1929) 381-382
68. Fonnum F. The 'compartmentation' of choline acetyltransferase within the synaptosome. Biochem. J. 103 (1967) 262-270
69. Franke H., and Illes P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol. Ther. 109 (2006) 297-324
70. Franke H., Grummich B., Hartig W., Grosche J., Regenthal R., Edwards R.H., Illes P., and Krügel U. Changes in purinergic signaling after cerebral injury-involvement of glutamatergic mechanisms?. Int. J. Dev. Neurosci. 24 (2006) 123-132
71. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., and Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000) 364-374
72. Fredholm B.B., Chen J.F., Masino S.A., and Vaugeois J.M. Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 385-412
73. Fujii T., and Kawashima K. An independent non-neuronal cholinergic system in lymphocytes. Jpn. J. Pharmacol. 85 (2001) 11-15
74. Gachet C. Regulation of platelet functions by P2 receptors. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 277-300
75. Galligan J.J., and North R.A. Pharmacology and function of nicotinic acetylcholine and P2X receptors in the enteric nervous system. Neurogastroenterol. Motil. 16 Suppl 1 (2004) 64-70
76. Gahring L.C., and Rogers S.W. Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. AAPS J. 7 (2006) E885-E894
77. Geerts H., and Grossberg G.T. Pharmacology of acetylcholinesterase inhibitors and N-methyl-d-aspartate receptors for combination therapy in the treatment of Alzheimer's disease. J. Clin. Pharmacol. 46 (2006) 8S-16S
78. Gever J.R., Cockayne D.A., Dillon M.P., Burnstock G., and Ford A.P. Pharmacology of P2X channels. Pflügers Arch. 452 (2006) 513-537
79. Giacobini E. Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol. Res. 50 (2004) 433-440
80. Gillespie J.H. The biological significance of the linkages in adenosine triphosphoric acid. J. Physiol. 80 (1934) 345-359
81. Goding J.W., Grobben B., and Slegers H. Physiological and pathophysiological functions of the ecto- nucleotide pyrophosphatase/phosphodiesterase family. BBA Mol. Basis. Dis. 1638 (2003) 1-19
82. Gotti C., and Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog. Neurobiol. 74 (2004) 363-396
83. Gotti C., Zoli M., and Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol. Sci. 27 (2006) 482-491
84. Gray J.H., Owen R.P., and Giacomini K.M. The concentrative nucleoside transporter family SLC28. Pflügers Arch. 447 (2004) 728-734
85. Gualix J., Fideu M.D., Pintor J., Rotllán P., Garcia-Carmona F., and Miras-Portugal M.T. Characterization of diadenosine polyphosphate transport into chromaffin granules from adrenal medulla. FASEB J. 11 (1997) 981-990
86. Gualix J., Pintor J., and Miras-Portugal M.T. Characterization of nucleotide transport into rat brain synaptic vesicles. J. Neurochem. 73 (1999) 1098-1104
87. Hahn M., Hahn S.L., Stone D.M., and Joh T.H. Cloning of the rat gene encoding choline acetyltransferase, a cholinergic neuron-specific marker. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 4387-4391
88. Holton F.A.P., and Holton P. The possibility that ATP is a transmitter a sensory nerve endings. J. Physiol. 119 Suppl. (1953) 50P-51P
89. Holton F.A.P., and Holton P. The capillary dilator substances in dry powder of spinal roolts. J. Physiol. 126 (1954) 124-140
90. Hoyle C.H., and Burnstock G. Atropine-resistant excitatory junction potentials in rabbit bladder are blocked by alpha,beta-methylene ATP. Eur. J. Pharmacol. 114 (1985) 239-240
91. Hoyle C.H.V., Hilderman R.H., Pintor J.J., Schlüter H., and King B.F. Diadenosine polyphosphates as extracellular signal molecules. Drug Dev. Res. 52 (2001) 260-273
92. Huang Y.J., Maruyama Y., Dvoryanchikov G., Pereira E., Chaudhari N., and Roper S.D. The role of pannexin 1 hemichannels in ATP release and cell-cell communication in mouse taste buds. Proc. Nat. Acad. Sci. U.S.A. 104 (2007) 6436-6441
93. Huidobrotoro J.P., and Donoso M.V. Sympathetic co-transmission: the coordinated action of ATP and noradrenaline and their modulation by neuropeptide Y in human vascular neuroeffector junctions. Eur. J. Pharmacol. 500 (2004) 27-35
94. Hulme E.C., Birdsall N.J., and Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 633-673
95. Hussl S., and Boehm S. Functions of neuronal P2Y receptors. Pflügers Arch. 452 (2006) 538-551
96. Illes P., and Ribeiro J.A. Molecular physiology of P2 receptors in the central nervous system. Eur. J. Pharmacol. 483 (2004) 5-17
97. Inoue K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol. Ther. 109 (2006) 210-226
98. Jahr C.E., and Jessell T.M. ATP excites a subpopulation of rat dorsal horn neurones. Nature 304 (1983) 730-733
99. Jia M., Li M.X., Fields R.D., and Nelson P.G. Extracellular ATP in activity-dependent remodeling of the neuromuscular junction. Dev. Neurobiol. 67 (2007) 924-932
100. Jo Y.H., and Schlichter R. Synaptic corelease of ATP and GABA in cultured spinal neurons. Nat. Neurosci. 2 (1999) 241-245
101. Jo Y.H., and Role L.W. Coordinate release of ATP and GABA at in vitro synapses of lateral hypothalamic neurons. J. Neurosci. 22 (2002) 4794-4804
102. Kaczmarek E., Koziak K., Sévigny J., Siegel J.B., Anrather J., Beaudoin A.R., Bach F.H., and Robson S.C. Identification and characterization of CD39 vascular ATP diphosphohydrolase. J. Biol. Chem. 271 (1996) 33116-33122
103. Kam W., Clauser E.M., Kim Y.S., Kan Y.W., and Rutter W.J. Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 8715-8719
104. Kapoor J.R., and Sladek C.D. Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release. J. Neurosci. 20 (2000) 8868-8875
105. Karczmar A.G. Loewi's discovery and the XXI century. Prog. Brain Res. 109 (1996) 1-27
106. Katz B. Quantal mechanism of neural transmitter release. Science 173 (1971) 123-126
107. Kennedy C. ATP as a cotransmitter in perivascular sympathetic nerves. J. Auton. Pharmacol. 16 (1996) 337-340
108. Khakh B.S. Molecular physiology of P2X receptors and ATP signalling at synapses. Nat. Rev. Neurosci. 2 (2001) 165-174
109. Khakh B.S., and North R.A. P2X receptors as cell-surface ATP sensors in health and disease. Nature 442 (2006) 527-532
110. Khakh B.S., Zhou X., Sydes J., Galligan J.J., and Lester H.A. State-dependent cross-inhibition between transmitter-gated cation channels. Nature 406 (2000) 405-410
111. 2 and α4β2 nicotinic channels measured with fluorescence resonance energy transfer and total internal reflection fluorescence microscopy. J. Neurosci. 25 (2005) 6911-6920
112. King A.E., Ackley M.A., Cass C.E., Young J.D., and Baldwin S.A. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharm. Sci. 27 (2006) 416-425
113. Kirkpatrick C.J., Bittinger F., Unger R.E., Kriegsmann J., Kilbinger H., and Wessler I. The non-neuronal cholinergic system in the endothelium: Evidence and possible pathobiological significance. Jpn. J. Pharmacol. 85 (2001) 24-28
114. Klapproth H., Reinheimer T., Metzen J., Munch M., Bittinger F., Kirkpatrick C.J., Hohle K.D., Schemann M., Racke K., and Wessler I. Non-neuronal acetylcholine, a signalling molecule synthesized by surface cells of rat and man. Naunyn-Schmiedeberg's Arch. Pharmacol. 355 (1997) 515-523
115. Klein R.L. Chemical composition of the large noradrenergic vesicles. In: Klein R., Lagercrantz H., and Zimmermann H. (Eds). Neurotransmitter Vesicles (1982), Academic Press, New York 133-174
116. Krishtal O.A., Marchenko S.M., and Pidoplichko V.I. Receptor for ATP in the membrane of mammalian sensory neurones. Neurosci. Lett. 35 (1983) 41-45
117. Kubo T., Fukuda K., Mikami A., Maeda A., Takahashi H., Mishina M., Haga T., Haga K., Ichiyama A., and Kangawa K. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature 323 (1986) 411-416
118. Kubo T., Maeda A., Sugimoto K., Akiba I., Mikami A., Takahashi H., Haga T., Haga K., Ichiyama A., and Kangawa K. Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett. 209 (1986) 367-372
119. Lanzafame A.A., Christopoulos A., and Mitchelson F. Cellular signaling mechanisms for muscarinic acetylcholine receptors. Receptors. Channels 9 (2003) 241-260
120. Lazarowski E.R., Boucher R.C., and Harden T.K. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol. Pharmacol. 64 (2003) 785-795
121. Lechner S.G., and Boehm S. Regulation of neuronal ion channels via P2Y receptors. Purinergic Signal. 1 (2004) 31-41
122. Loewi O. On the humoral transmission from nerve to the heart I. Communication. Pflügers Arch. Ges. Phsyiol. 189 (1921) 239-242
123. Loewi O., and Navratil E. On the humoral transmission from nerve to the heart X. Communication. On the fate of the Vagusstoff. Pflügers Arch. Ges. Physiol. 214 (1926) 678-688
124. Loewi O., and Navratil E. On the humoral transmission from nerve to the heart XI. Communication. On the mechanism of physostigmin and ergotamin on the vagus nerve. Pflügers Arch. Ges. Physiol. 214 (1926) 689-696
125. Lohmann K. On the phosphate fraction in muscle. Naturwissenschaften 17 (1929) 624-625
126. Lohmann K. Structure of adenopyrophosphoric acid and adenosine diphosphoric acid. Biochem. Z. 282 (1935) 120-123
127. Lu B., and Fu W.M. Regulation of postsynaptic responses by calcitonin gene related peptide and ATP at developing neuromuscular junctions. Can. J. Physiol. Pharmacol. 73 (1995) 1050-1056
128. 7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum. Mol. Genet. 15 (2006) 2438-2445
129. Luqmani Y.A. Nucleotide uptake by isolates cholinergic synaptic vesicles: evidence for a carrier of adenosine 5′-triphosphate. Neuroscience 6 (1981) 1011-1021
130. Lustig K.D., Shiau A.K., Brake A.J., and Julius D. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 5113-5117
131. Lythgoe B., and Todd A.R. Structure of adenosine di- and tri-phosphate. Nature 155 (1945) 695-696
132. Mann T. Studies on the metabolism of semen: 1. General aspects. Occurrence and distribution of cytochrome, certain enzymes and coenzymes. Biochem. J. 39 (1945) 451-458
133. 1 receptor. J. Neurosci. 27 (2007) 1456-1466
134. Maruyama K. The discovery of adenosine triphosphate and the establishment of its structure. J. Hist. Biol. 24 (1991) 145-154
135. Massoulie J., Anselmet A., Bon S., Krejci E., Legay C., Morel N., and Simon S. The polymorphism of acetylcholinesterase: post-translational processing, quaternary associations and localization. Chem. Biol. Interact. 119-120 (1999) 29-42
136. Mellor E.A., Frank N., Soler D., Hodge M.R., Lora J.M., Austen K.F., and Boyce J.A. Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 11589-11593
137. Millán J.L. Mammalian Alkaline Phosphatases from Biology to Applications in Medicine and Biotechnology (2006), Wiley-VCH Verlag GmbH & Co, Weinheim, Germany
138. Millán J.L. Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal. 2 (2006) 335-341
139. Misumi Y., Ogata S., Hirose S., and Ikehara Y. Primary structure of rat liver 5′-nucleotidase deduced from the Cdna Presence of the COOH-terminal hydrophobic domain for possible post-translational modification by glycophospholipid. J. Biol. Chem. 265 (1990) 2178-2183
140. 11 purinergic receptor in human granulocytes. J. Biol. Chem. 281 (2006) 31419-31429
141. Müller C.E., Iqbal J., Baqi Y., Zimmermann H., Röllich A., and Stephan H. Polyoxometalates-A new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Biorog. Med. Chem. Lett. 16 (2006) 5943-5947
142. Nachmansohn D., and Machado A.L. The formation of acetylcholine A new enzyme "choline acetylase. J. Neurophysiol. 6 (1943) 397-404
143. Nagy A., Baker R.R., Morris S.J., and Whittaker V.P. The preparation and characterization of synaptic vesicles of high purity. Brain Res. 109 (1976) 285-309
144. Neher E., and Sakmann B. Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature 260 (1976) 799-802
145. Newhouse P., Singh A., and Potter A. Nicotine and nicotinic receptor involvement in neuropsychiatric disorders. Curr. Top. Med. Chem. 4 (2004) 267-282
146. Newsom-Davis J. Lambert-Eaton myasthenic syndrome. Rev. Neurol. (Paris) 160 (2004) 177-180
147. 3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J. 17 (1998) 3016-3028
148. Noda M., Takahashi H., Tanabe T., Toyosato M., Furutani Y., Hirose T., Asai M., Inayama S., Miyata T., and Numa S. Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature 299 (1982) 793-797
149. Nörenberg W., and Illes P. Neuronal P2X receptors: localisation and functional properties. Naunyn-Schmiedeberg's Arch. Pharmacol. 362 (2000) 324-339
150. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 82 (2002) 1013-1067
151. North R.A., and Verkhratsky A. Purinergic transmission in the central nervous system. Pflügers Arch. Eur. J. Physiol. 452 (2006) 479-485
152. Obermüller S., Lindqvist A., Karanauskaite J., Galvanovskis J., Rorsman P., and Barg S. Selective nucleotide-release from dense-core granules in insulin-secreting cells. J. Cell Sci. 118 (2005) 4271-4282
153. Okuda T., Haga T., Kanai Y., Endou H., Ishihara T., and Katsura I. Identification and characterization of the high-affinity choline transporter. Nat. Neurosci. 3 (2000) 120-125
154. Okuda T., and Haga T. High-affinity choline transporter. Neurochem. Res. 28 (2003) 483-488
155. Pankratov Y., Castro E., Miras-Portugal M.T., and Krishtal O. A purinergic component of the excitatory postsynaptic current mediated by P2X receptors in the CA1 neurons of the rat hippocampus. Eur. J. Neurosci. 10 (1998) 3898-3902
156. Pankratov Y., Lalo U., Verkhratsky A., and North R.A. Vesicular release of ATP at central synapses. Pflügers Arch. 452 (2006) 589-597
157. Pankratov Y., Lalo U., Verkhratsky A., and North R.A. Quantal release of ATP in mouse cortex. J. Gen. Physiol. 129 (2007) 257-265
158. Parsons S.M. Transport mechanisms in acetylcholine and monoamine storage. FASEB J. 14 (2000) 2423-2434
159. Parsons S.M., Bahr B.A., Rogers G.A., Clarkson E.D., Noremberg K., and Hicks B.W. Acetylcholine transporter vesamicol receptor pharmacology and structure. Prog. Brain Res. 98 (1993) 175-181
160. 7 receptors exert a permissive role on the activation of release-enhancing presynaptic alpha 7 nicotinic receptors co- existing on rat neocortex glutamatergic terminals. Neuropharmacology 50 (2006) 705-713
161. Picher M., and Boucher R.C. Human airway ecto-adenylate kinase-A mechanism to propagate ATP signaling on airway surfaces. J. Biol. Chem. 278 (2003) 11256-11264
162. Pintor J., Kowalewski H.J., Torres M., Miras-Portugal M.T., and Zimmermann H. Synaptic vesicle storage of diadenosine polyphosphates in the Torpedo electric organ. Neurosci. Res. Commun. 10 (1992) 9-15
163. Prado M.A.M., Reis R.A.M., Prado V.F., deMello M.C., Gomez M.V., and deMello F.G. Regulation of acetylcholine synthesis and storage. Neurochem. Int. 41 (2002) 291-299
164. Racke K., Juergens U.R., and Matthiesen S. Control by cholinergic mechanisms. Eur. J. Pharmacol. 533 (2006) 57-68
165. Reigada D., Diez-Perez I., Gorostiza P., Verdaguer A., deAranda I.G., Pineda O., Vilarrasa J., Marsal J., Blasi J., Aleu J., and Solsona C. Control of neurotransmitter release by an internal gel matrix in synaptic vesicles. Proc. Nat. Acad. Sci. U.S.A. 100 (2003) 3485-3490
166. Reimer R.J., Fon E.A., and Edwards R.H. Vesicular neurotransmitter transport and the presynaptic regulation of quantal size. Curr. Opin. Neurobiol. 8 (1998) 405-412
167. Richardson P.J., and Brown S.J. ATP release from affinity-purified rat cholinergic nerve terminals. J. Neurochem. 48 (1987) 622-630
168. Ripoll N., Bronnec M., and Bourin M. Nicotinic receptors and schizophrenia. Curr. Med. Res. Opin. 20 (2004) 1057-1074
169. Roberts J.A., Vial C., Digby H.R., Agboh K.C., Wen H., Atterbury-Thomas A., and Evans R.J. Molecular properties of P2X receptors. Pflügers Arch. 452 (2006) 486-500
170. Robertson S.J., Ennion S.J., Evans R.J., and Edwards F.A. Synaptic P2X receptors. Curr. Opin. Neurobiol. 11 (2001) 378-386
171. Robson S.C., Wu Y., Sun X.F., Knosalla C., Dwyer K., and Enjyoji K. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin. Thromb. Hemostasis 31 (2005) 217-233
172. Robson S.C., Sévigny J., and Zimmermann H. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal. 2 (2006) 409-430
173. Rodrigues R.J., Almeida T., Demendonca A., and Cunha R.A. Interaction between P2X and nicotinic acetylcholine receptors in glutamate nerve terminals of the rat hippocampus. J. Mol. Neurosci. 30 (2006) 173-176
174. Rohstein A., and Meier R. The relationship of the cell surface to metabolism I. Phosphatases in the cell surface of living yeast cells. J. Cell. Comp. Physiol. 32 (1948) 77-95
175. Romanov R.A., Rogachevskaja O.A., Bystrova M.F., Jiang P.H., Margolskee R.F., and Kolesnikov S.S. Afferent neurotransmission mediated by hemichannels in mammalian taste cells. EMBO J. 26 (2007) 657-667
176. Sakmann B. Elementary steps in synaptic transmission revealed by currents through single ion channels. Science 256 (1992) 503-512
177. Santos T.G., Souza D.O., and Tasca C.I. GTP uptake into rat brain synaptic vesicles. Brain Res. 1070 (2006) 71-76
178. Schläfer M., Volknandt W., and Zimmermann H. Putative synaptic vesicle nucleotide transporter identified as glyceraldehyde-3-phosphate dehydrogenase. J. Neurochem. 63 (1994) 1924-1931
179. Schumacher M., Camp S., Maulet Y., Newton M., Phee-Quigley K., Taylor S.S., Friedmann T., and Taylor P. Primary structure of acetylcholinesterase: implications for regulation and function. Fed. Proc. 45 (1986) 2976-2981
180. Sher E., Chen Y., Sharples T.J., Broad L.M., Benedetti G., Zwart R., McPhie G.I., Pearson K.H., Baldwinson T., and De F.G. Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity. Curr. Top. Med. Chem. 4 (2004) 283-297
181. Silman I., and Sussman J.L. Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. Curr. Opin. Pharmacol. 5 (2005) 293-302
182. Siow N.L., Xie H.Q., Choi R.C., and Tsim K.W. ATP induces the post-synaptic gene expression in neuron-neuron synapses: Transcriptional regulation of AChE catalytic subunit. Chem. Biol. Interact. 157-158 (2005) 423-426
183. Sneddon P. Electrophysiology of autonomic neuromuscular transmission involving ATP. J. Auton. Nerv. Syst. 81 (2000) 218-224
184. Sneddon P., and Burnstock G. Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur. J. Pharmacol. 100 (1984) 85-90
185. Sneddon P., Westfall T.D., Todorov L.D., Mihaylova-Todorova S., Westfall D.P., and Kennedy C. Modulation of purinergic neurotransmission. Prog. Brain Res. 120 (1999) 11-20
186. Soreq H., and Seidman S. Acetylcholinesterase-new roles for an old actor. Nat. Rev. Neurosci. 2 (2001) 294-302
187. Spentchian M., Brun-Heath I., Taillandier A., Fauvert D., Serre J.L., Simon-Bouy B., Carvalho F., Grochova I., Mehta S.G., Muller G., Oberstein S.L., Ogur G., Sharif S., and Mornet E. Characterization of missense mutations and large deletions in the ALPL gene by sequencing and quantitative multiplex PCR of short fragments. Genet. Test. 10 (2006) 252-257
188. Sperlágh B., and Vizi E.S. Neuronal synthesis, storage and release of ATP. Semin. Neurosci. 8 (1996) 175-186
189. 7 receptors in the nervous system. Prog. Neurobiol. 78 (2006) 327-346
190. Stefan C., Jansen S., and Bollen M. Modulation of purinergic signaling by NNP-type ectophosphodiesterases. Purinergic Signal. 2 (2006) 361-370
191. Stjärne L., and Stjärne E. Geometry, kinetics and plasticity of release and clearance of ATP and noradrenaline as sympathetic cotransmitters: Roles for the neurogenic contraction. Prog. Neurobiol. 47 (1995) 45-94
192. Stjärne L., Astrand P., Bao X., Gonon F., Msghina M., and Stjärne E. Spatiotemporal pattern of quantal release of ATP and noradrenaline from sympathetic nerves: consequences for neuromuscular transmission. Adv. Second Messenger Phosphoprotein Res. 29 (1994) 461-496
193. Stojilkovic S.S., and Koshimizu T.A. Signaling by extracellular nucleotides in anterior pituitary cells. Trends Endocrinol. Metab. 12 (2001) 218-225
194. Sussman J.L., Harel M., Frolow F., Oefner C., Goldman A., Toker L., and Silman I. Atomic structure of acetylcholinesterase from Torpedo californica-A prototypic acetylcholine-binding protein. Science 253 (1991) 872-879
195. Terkeltaub R. Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing in calcification. Purinergic Signal. 2 (2006) 371-377
196. Todd K.J., and Robitaille R. Purinergic modulation of synaptic signalling at the neuromuscular junction. Pflügers Arch. 452 (2006) 608-614
197. Tsim K.W., and Barnard E.A. The signaling pathways mediated by P2Y nucleotide receptors in the formation and maintenance of the skeletal neuromuscular junction. Neurosignals 11 (2002) 58-64
198. Tsim K.W.K., Choi R.C.Y., Siow N.L., Cheng A.W.M., Ling K.K.Y., Jiang J.X.S., Tung E.K.K., Lee H.H.C., Xie Q.H., Simon J., and Barnard E.A. ATP induces post-synaptic gene expressions in vertebrate skeletal neuromuscular junctions. J. Neurocytol. 32 (2003) 603-617
199. 4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
200. Tucek S. Regulation of acetylcholine synthesis in the Brain. J. Neurochem. 44 (1985) 11-24
201. Unwin N. The Croonian Lecture 2000 Nicotinic acetylcholine receptor and the structural basis of fast synaptic transmission. Philos. Trans. R. Soc. Lond. B 355 (2000) 1813-1829
202. Usdin, T.B., Eiden, L.E., Bonner, T.I., Erickson, J.D., 1995. Molecular biology of the vesicular ACh transporter. Trends Neurosci. 18, 218-224.
203. Valera S., Hussy R.J., Evans N., Adami R., North R.A., Surprenant A., and Buell G. A new class of ligand gated ion channel defined by P2X receptor for extracellular ATP. Nature 371 (1994) 516-519
204. van Driel I.R., Wilks A.F., Pietersz G.A., and Goding J.W. Murine plasma cell membrane antigen PC-1: molecular cloning of cDNA and analysis of expression. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 8619-8623
205. Vizi E.S., and Sperlágh B. Receptor- and carrier-mediated release of ATP of postsynaptic origin: cascade transmission. Prog. Brain Res. 120 (1999) 159-169
206. Volknandt W., and Zimmermann H. Acetylcholine, ATP, and proteoglycan are common to synaptic vesicles isolated from the electric organs of electric eel and electric catfish as well as from rat diaphragm. J. Neurochem. 47 (1986) 1449-1462
207. von Kügelgen I. Modulation of neural ATP release through presynaptic receptors. Semin. Neurosci. 8 (1996) 247-257
208. von Kügelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol. Ther. 110 (2006) 415-432
209. von Kügelgen I., and Starke K. Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol. Sci. 12 (1991) 319-324
210. 2+)-apyrase. J. Biol. Chem. 271 (1996) 9898-9901
211. Webb T.E., Simon J., Krishek B.J., Bateson A.N., Smart T.G., King B.F., Burnstock G., and Barnard E.A. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324 (1993) 219-225
212. Wenkstern T.W., and Engelhart W.A. The adenosine polyphosphatase localized on the surface of nucleated red corpuscles. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 76 (1959) 422-431
213. Wessler I., Kirkpatrick C.J., and Racke K. The cholinergic 'pitfall': Acetylcholine, a universal cell molecule in biological systems, including humans. Clin. Exp. Pharmacol. Physiol. 26 (1999) 198-205
214. Wessler I., Kilbinger H., Bittinger F., and Kirkpatrick C.J. The biological role of non-neuronal acetylcholine in plants and humans. Jpn. J. Pharmacol. 85 (2001) 2-10
215. Westfall D.P., Sedaa K.O., Shinozuka K., Bjur R.A., and Buxton I.L. ATP as a cotransmitter. Ann. N.Y. Acad. Sci. 603 (1990) 300-310
216. White N., and Burnstock G. P2 receptors and cancer. Trends Pharmacol. Sci. 27 (2006) 211-217
217. Whittaker V.P., and Sheridan M.N. The morphology and acetylcholine content of isolated cerebral cortical synaptic vesicles. J. Neurochem. 12 (1964) 363-372
218. Winkler H. The adrenal chromaffin granule-A model for large dense core vesicles of endocrine and nervous tissue. J. Anat. 183 (1993) 237-252
219. Witzemann V. Development of the neuromuscular junction. Cell Tissue Res. 326 (2006) 263-271
220. Wonnacott S., Sidhpura N., and Balfour D.J. Nicotine: from molecular mechanisms to behaviour. Curr. Opin. Pharmacol. 5 (2005) 53-59
221. Yegutkin G.G., Henttinen T., Samburski S.S., Spychala J., and Jalkanen S. The evidence for two opposite, ATP-generating and ATP- consuming, extracellular pathways on endothelial and lymphoid cells. Biochem. J. 367 (2002) 121-128
222. Zapata P. Is ATP a suitable co-transmitter in carotid body arterial chemoreceptors?. Respir. Physiol. Neurobiol. 157 (2007) 106-115
223. Zimmerman G., and Soreq H. Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission. Cell Tissue Res. 326 (2006) 655-669
224. Zimmermann H. Biochemistry of the isolated cholinergic vesicles. In: Klein R., Lagercrantz H., and Zimmermann H. (Eds). Neurotransmitter Vesicles (1982), Academic Press, New York 271-304
225. Zimmermann H. Cholinergic synaptic vesicles. Handb. Exp. Pharmacol. 86 (1988) 349-382
226. Zimmermann H. 5'-Nucleotidase - molecular structure and functional aspects. Biochem. J. 285 (1992) 345-365
227. Zimmermann H. Signalling via ATP in the nervous system. Trends Neurosci. 17 (1994) 420-426
228. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg's Arch. Pharmacol. 362 (2000) 299-309
229. Zimmermann H. Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Dev. Res. 52 (2001) 44-56
230. Zimmermann H. Ecto-nucleotidases. In: Abbracchio M.P., and Williams M. (Eds). Handbook of Experimental Pharmacology. Purinergic and Pyrimidergic Signalling 151/I (2001), Springer Verlag, Heidelberg 209-250
231. Zimmermann H. Ecto-nucleotidases in the nervous system. Novartis Found. Symp. 275 (2006) 113-128
232. Zimmermann H., Dowdall M.J., and Lane D.A. Purine salvage at the cholinergic nerve endings of the Torpedo electric organ: The central role of adenosine. Neuroscience 4 (1979) 979-993